Company intelligence / Profile preview

Hsu Gamma Investment

Road Town, British Virgin Islands

Ownership: Private
Development stage: Other

Overview

Hsu Gamma Investment is a private investment holding company primarily focused on the life sciences and healthcare sectors. It is most recognized as a significant shareholder in major global contract research and manufacturing organizations, specifically WuXi AppTec and WuXi Biologics. The entity serves as a strategic investment vehicle for the founders and key leadership of the WuXi group, including Dr. Ge Li. While it does not conduct independent research or development of therapeutics, its financial activities and equity positions are central to the strategic operations of the WuXi ecosystem. The company is instrumental in the financing and capital management of leading biotech service providers.

Industry: Investors

Partnerships

WuXi AppTecWuXi Biologics

Beyond the preview

Go deeper on Hsu Gamma Investment.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hsu Gamma Investment.

Explore the full profile